<SEC-DOCUMENT>0000950170-24-097206-index.html : 20240814 <SEC-HEADER>0000950170-24-097206.hdr.sgml : 20240814 <ACCEPTANCE-DATETIME>20240814171506 ACCESSION NUMBER: 0000950170-24-097206 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240813 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240814 DATE AS OF CHANGE: 20240814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eledon Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001404281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36620 FILM NUMBER: 241209526 BUSINESS ADDRESS: STREET 1: 19800 MACARTHUR BLVD. STREET 2: SUITE 250 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 949-238-8090 MAIL ADDRESS: STREET 1: 19800 MACARTHUR BLVD. STREET 2: SUITE 250 CITY: IRVINE STATE: CA ZIP: 92612 FORMER COMPANY: FORMER CONFORMED NAME: Novus Therapeutics, Inc. DATE OF NAME CHANGE: 20170511 FORMER COMPANY: FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc DATE OF NAME CHANGE: 20070622 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>eldn-20240814.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: eldn-20240814.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>eldn-ex99_1.htm <DESCRIPTION>EX-99.1 <TEXT> Document 2 - file: eldn-ex99_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>img20068692_0.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: img20068692_0.jpg
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>4 <FILENAME>eldn-20240814.xsd <DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT <TEXT> Document 4 - file: eldn-20240814.xsd
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>6 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 6 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EXCEL <SEQUENCE>7 <FILENAME>Financial_Report.xlsx <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 7 - file: Financial_Report.xlsx
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>8 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 8 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>9 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 9 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>11 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 11 - file: FilingSummary.html
Document 11 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>14 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 14 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>15 <FILENAME>0000950170-24-097206-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 15 - file: 0000950170-24-097206-xbrl.zip
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>16 <FILENAME>eldn-20240814_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 16 - file: eldn-20240814_htm.html
Document 16 - RAW XML: eldn-20240814_htm.xml
</DOCUMENT> </SEC-DOCUMENT>